Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Products - Amgen
Our Products. Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
Discover Amgen and Search Our Jobs and Careers in Biotechnology
Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.
Press Releases - Amgen Inc.
amgen announces positive results for phase 3 registrational trial evaluating uplizna® (inebilizumab-cdon) for treatment of immunoglobulin g4-related disease (igg4-rd)
Contact Us - Amgen
Patient Assistance. For reimbursement options and information on help paying for Amgen medications in the U.S., healthcare professionals and patients can also visit amgensupportplus.com.
Science - Amgen
Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.
Annual Reports - Amgen Inc.
Chairman and CEO Letter and Amgen Inc. 2016 Annual Report. 03.31.2016. Chairman and CEO Letter and Amgen Inc. 2015 Annual Report. 04.02.2015. 2015 Proxy Statement. 03.26.2015. Chairman and CEO Letter and Amgen Inc. 2014 Annual Report. 03.27.2014. Chairman and CEO Letter and Amgen Inc. 2013 Annual Report.
Amgen Worldwide
At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes.
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
Aug 4, 2022 · Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease. Tavneos Adds to Amgen 's Decades-Long Leadership in Inflammation and Nephrology.
Newsroom - Amgen
Tweets by Amgen. Amgen is committed to providing the media with timely and accurate information. This section offers key resources for journalists, editors and other media professionals.
- Some results have been removed